China’s bonded refurbishment policy seeks to ease pressures for medical device businesses

Kenneth Leung of KPMG China considers how the relaxation of restrictions on bonded refurbishment can potentially ease supply chain disruptions encountered by medical device businesses in China.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: